Who invested in Thetis Pharmaceuticals?
Thetis Pharmaceuticals's investors include Connecticut Innovations, National Institutes of Health and Stonehenge Capital.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$16Mraised across 3 rounds since 2011, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $5.7M sold, first sale Dec 2012
Reported by masshightech.comSEC filing: $1.5M sold, first sale Aug 2011
From the SEC filings it signed: 5 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Thetis Pharmaceuticals's investors include Connecticut Innovations, National Institutes of Health and Stonehenge Capital.
Thetis Pharmaceuticals has raised $16M across 3 rounds since 2011.
Thetis Pharmaceuticals's most recent round was a Debt of $9.0M in Jan 2025.
Its most recent round, $9.0M in Jan 2025, is also its largest on record.
Thetis Pharmaceuticals's first round on record, in Aug 2011, was backed by Connecticut Innovations and Stonehenge Capital.
Thetis Pharmaceuticals's latest named round is a Debt, in Jan 2025.
Thetis Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.